Zhejiang Cheng Yi Pharmaceutical Co., Ltd. provided earnings guidance for the first half of 2018. For the period, the company predicts that the net profit in-between RMB 44 million and RMB 46 million, with an increase of between RMB 13.95 million and RMB 15.95 million and an increase of between 46.4% and 53.1% compared with the same period of the year before. The net profit after excluding extraordinary profit and loss will be between RMB 44 million and RMB 46 million, with an increase of between RMB 17.2 million and RMB 19.2 million and an increase of between 64.2% and 71.6% compared with the same period of the year before.